首页> 外国专利> The use of angiotensin I derivative as an agent for the treatment and prevention of infarction-related cardiac injuries and disorders

The use of angiotensin I derivative as an agent for the treatment and prevention of infarction-related cardiac injuries and disorders

机译:血管紧张素I衍生物在治疗和预防与梗塞相关的心脏损伤和疾病中的用途

摘要

The present invention relates generally to a method for the treatment and/or prophylaxis of infarction-related cardiac injuries and disorders. More particularly, the present invention contemplates a method for the treatment and/or prophylaxis of myocardial infarction and heart failure and/or related conditions. The method of the present invention is practised by the administration of a derivative of angiotensin I. In a preferred embodiment, the angiotensin I is des-Aspartate-angiotensin I. The present invention further contemplates compositions for use in the treatment and/or prophylaxis of infarction-related cardiac injuries and disorders such as but not limited to myocardial infarction and heart failure.
机译:本发明总体上涉及一种用于治疗和/或预防与梗塞有关的心脏损伤和病症的方法。更具体地,本发明考虑了一种用于治疗和/或预防心肌梗塞和心力衰竭和/或相关病症的方法。通过给予血管紧张素I的衍生​​物来实施本发明的方法。在一个优选的实施方案中,血管紧张素I为des-天冬氨酸-血管紧张素I。本发明进一步考虑了用于治疗和/或预防血管紧张素I的组合物。与梗塞有关的心脏损伤和疾病,例如但不限于心肌梗塞和心力衰竭。

著录项

  • 公开/公告号AU2002311741B2

    专利类型

  • 公开/公告日2007-11-22

    原文格式PDF

  • 申请/专利权人 NATIONAL UNIVERSITY OF SINGAPORE;

    申请/专利号AU20020311741

  • 发明设计人 MENG KWOON SIM;

    申请日2002-06-27

  • 分类号A61K45;A61K38;A61K38/08;A61K38/55;A61P9;A61P9/04;A61P9/06;A61P9/10;F24V30;

  • 国家 AU

  • 入库时间 2022-08-21 20:03:10

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号